Sagittarius Life Science Corp. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sagittarius Life Science Corp. with three other
companies in this sector in TAIWAN :
Tien Liang Biotech Co Ltd
sales of 435.86 million Taiwanese Dollars [US$14.90 million]
Genovate Biotechnology Co., Limited
(465.76 million Taiwanese Dollars [US$15.92 million]
of which 94%
was Medicine Manufacturing), and
Johnson Chemical Pharmaceutical Works Co Ltd
(425.34 million Taiwanese Dollars [US$14.54 million]
Sagittarius Life Science Corp. reported sales of 438.72 million Taiwanese Dollars (US$15.00 million)
December of 2019.
increase of 6.6%
versus 2018, when the company's sales were 411.41 million Taiwanese Dollars .
Despite this increase, sales are still
below the level achieved in 2017, when Sagittarius Life Science Corp.
reported sales of 462.82 million Taiwanese Dollars .
The sales level in 2019 was fairly close to the level five years ago: in 2014, Sagittarius Life Science Corp. had sales
of 438.70 million Taiwanese Dollars .